TotalMarketCap

Regentis Biomaterials

RGNTNYSE IsraelHealth CareIndustrial Specialties

Market cap

$8.429 M

$1.20 -9.09%

Close of 6 Nov 2026

As of 6 Nov 2026, Regentis Biomaterials (RGNT) has a market capitalization of $8.43M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$13.6M

Loss-making

Shares outstanding

5,179,378

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Industrial Specialties, ranked by market cap

All 55 →
  1. #51Cuprina Holdings (Cayman)CUPR$13.5M
  2. #52HeartSciencesHSCS$12.8M
  3. #53CollPlant BiotechnologiesCLGN$12.4M
  4. #54Regentis BiomaterialsRGNT$8.43M
  5. #55Bone BiologicsBBLG$1.09M

What if Regentis Biomaterials were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,020,101

Per share 3,350,084× higher

Bitcoin $1.53T

$217,520.69

Per share 181,267× higher

Apple $5.02T

$714,100.11

Per share 595,083× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Regentis Biomaterials are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.